Virtual Medicinal Product (VMP)
-
Mometasone 400micrograms/dose dry powder inhaler
Name Details
Current Name
Mometasone 400micrograms/dose dry powder inhaler
|
Start Date
16-08-2006
|
End Date
|
Previous Name
Mometasone 400micrograms/actuation dry powder inhaler
|
Start Date
10-03-2003
|
End Date
15-08-2006
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- dose
- Unit Dose UOM
- dose
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Inhalation
- Form
- Inhalation powder
- Ontology Form/Route
- powderinhalation.inhalation
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
R03BA07
BNF |
Current BNF
03020000
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
03020000
|
Start Date
01-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
38895611000001107 |
19-08-2020 |
|
408013007 |
19-08-2005 |
18-08-2020 |
4053911000001106 |
10-03-2003 |
18-08-2005 |
VMP Ingredients
VMP ingredients table
Mometasone furoate |
Based on Ingredient Substance |
|
400 microgram |
1 dose |
Name
Mometasone furoate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
400
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Mometasone
-
VMP
(Current) Mometasone 400micrograms/dose dry po...
Virtual Medicinal Product Pack (VMPP) Information